Rapid Therapeutic Science Laboratories, Inc operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company develops a new method of formulation and manufacturing to deliver pure CBD, THC, and combinations in legal jurisdictions to consumers. It holds a sublicense agreement to access to certain technology regarding the Rxoid metered dose inhaler, which is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. It serves customers in the State of Texas. The company was founded on February 22, 2013 and is headquartered in Dallas, TX.